Dr. Giordano Featured in Forbes Article on COVID-19 Antibody Tests in Italy and USA | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« Expanding 3D Printing in Cardiology

Special COVID-19 Christopher Magazine »

Dr. Giordano Featured in Forbes Article on COVID-19 Antibody Tests in Italy and USA

May 10, 2020 by sjwilliamspa

Dr. Giordano Featured in Forbes Article on COVID-19 Antibody Tests in Italy and USA

Reporter: Stephen J. Williams, PhD

via Dr. Giordano Featured in Forbes Article on COVID-19 Antibody Tests in Italy and USA

Posted in Biomarkers: Inflammation, Cancer Researchers Fighting COVID-19, Coronavirus Gene Expression, COVID-19, COVID-19, COVID-19 effects on Human Heart, COVID-19: Pandemic Surgery Guidance, Diagnostic Immunology, Diagnostics and Lab Tests, Economic Impact of Coronavirus Pandemic, Evolution of Biology Through Culture, Frontiers in Cardiology and Cardiovascular Disorders, Immune-Mediation (independent immunopathology: lung and reticuloendothelial system), Interviews with Key Opinion Leaders (KOLs), number of asymptomatic infections, Population Health Management, Population Health Management, Genetics & Pharmaceutical, SAR-Cov-2 a vasculotropic (blood vessels) RNA Virus, Scientific Publishing, Systemic Inflammatory Diseases as CVD Risk | Tagged #italy, antibody tests, COVID-19, diagnostic antibody, diagnostic testing, Forbes, forbes magazine, immunoassay, key opinion leaders, SARS-CoV-2, scientific leaders | Leave a Comment

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 2,000 other subscribers
Recent Posts
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: